What is the difference between Alpha-MSH and Triptorelin?

Alpha-MSH: Melanocortin peptide; activates MC1R (pigmentation/anti-inflammatory), MC3R (energy balance), MC4R (appetite); suppresses NF-κB and pro-inflammatory cytokines Triptorelin: Potent GnRH agonist; single pulse stimulates LH/FSH surge and restores HPG axis after suppression (e.g., post-steroid cycle)

Is Alpha-MSH FDA approved?

Alpha-MSH is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Triptorelin FDA approved?

Triptorelin is FDA approved (FDA status current as of 2000-06-15). This regulatory status is provided for research and educational context only.

How is Alpha-MSH administered in research settings?

In research settings, Alpha-MSH is typically administered via the subcutaneous or intranasal routes. PeptideBase does not provide dosing or administration instructions.

How is Triptorelin administered in research settings?

In research settings, Triptorelin is typically administered via the subcutaneous or intramuscular routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Alpha-MSH vs Triptorelin

Peptide Comparison

Alpha-MSH vs Triptorelin

Both are Reproductive & Hormonal peptides.

Alpha-MSH

Alpha-Melanocyte Stimulating Hormone

RecoveryNot EvaluatedResearch Only

Half-life: ~3-5 minutes (plasma)

No providers listed yet

Full Alpha-MSH profile →

Triptorelin

Decapeptyl

Sexual HealthFDA ApprovedPrescription

Half-life: ~7-8 hours (single dose) / ~5-7 weeks (depot form)

1 providers listed

Full Triptorelin profile →

Bottom line

Triptorelin is FDA-approved, while Alpha-MSH is not evaluated — the clearest structural difference between them.

Quick Verdict

Alpha-MSH

Evidence

Emerging Clinical

Half-life

~3-5 minutes (plasma)

Triptorelin

Evidence

Established Clinical

Half-life

~7-8 hours (single dose) / ~5-7 weeks (depot form)

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Triptorelin
Further along in FDA review	Triptorelin
Less frequent dosing (longer half-life)	Triptorelin
More provider options (0 vs 1)	Triptorelin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Alpha-MSH

Triptorelin

Mechanism Family

Reproductive & Hormonal

Half-life

~3-5 minutes (plasma)

~7-8 hours (single dose) / ~5-7 weeks (depot form)

FDA Status

not evaluated

approved

Admin Routes

subcutaneous, intranasal

subcutaneous, intramuscular

Availability

Research Only

Prescription

Providers

None listed

1 listed

FDA Update

—

Jun 2000

Avail. Notes

Endogenous 13-aa neuropeptide. No FDA-approved drug. Bremelanotide (PT-141/Vyleesi) is an approved derivative but a distinct compound. Not on FDA 503A bulks list. Research use only.

FDA-approved GnRH agonist. Brand: Trelstar (NDA 020726, Jun 2000). Indicated for advanced prostate cancer. Also used off-label for precocious puberty and chemical castration. Prescription only.

Research Evidence

Alpha-MSH

Emerging ClinicalCohort study · 12 key studies · most recent 2026

Triptorelin

Established ClinicalMeta-analysis · 8 key studies · most recent 2026

Research Citations

Alpha-MSH

Cohort2026 · Chem Biodivers

Depigmenting Effects of Vitex rotundifolia Cone Essential Oil in Melanocytes and Its Chemical Composition.

Cohort2026 · Sci Rep

Antrodia cinnamomea extract exhibits anti-melanogenic and anti-photoaging effects: potential for cosmetic and…

Cohort2026 · Appl Radiat Isot

Preclinical assessment of (177)Lu-DOTA-Pip-Nle-CycMSH(hex): In vivo evaluation and human dosimetry estimation.

Cohort2026 · Sci Rep

Hypothalamic orexigenic and anorexigenic neuropeptides in the rotenone model of Parkinson's disease.

+8 more

Triptorelin

Meta-analysis2026 · J Coll Physicians Surg Pak

GnRH Agonists and Antagonists in IVF/ICSI Cycles of PCOS Women: A Network Meta-Analysis.

RCT2016 · Journal of Pediatric Endocrinology and Metabolism

Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty

Cohort2026 · J Med Case Rep

In vitro fertilization-frozen embryo transfer in a patient with gonadotroph adenoma: Exacerbation of ovarian…

Cohort2026 · Zhongguo Dang Dai Er Ke Za Zhi

[Efficacy of the 3-month formulation of triptoreli in children with idiopathic central precocious puberty].

+4 more

About Alpha-MSH

Melanocortin peptide; activates MC1R (pigmentation/anti-inflammatory), MC3R (energy balance), MC4R (appetite); suppresses NF-κB and pro-inflammatory cytokines

Research Areas

anti-inflammatoryappetite suppressionthermoregulationskin pigmentation

About Triptorelin

Potent GnRH agonist; single pulse stimulates LH/FSH surge and restores HPG axis after suppression (e.g., post-steroid cycle)

Research Areas

HPG axis restarttestosterone restorationHPTA recovery

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Alpha-MSH

Reported (Unverified — Pending Clinical Review)

melanoma historyuncontrolled hypertension

No established clinical contraindications

Triptorelin

Reported (Unverified — Pending Clinical Review)

ongoing TRTactive hormonal therapy

No established clinical contraindications

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Find Providers

Where to source these peptides

Providers offering

Alpha-MSH

Browse directory →

Providers offering

Triptorelin

1 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Reproductive & Hormonal Comparisons

Browse all peptides →

Educational research tools — not medical advice.